The liver/islet high-K, facilitated glucose transporter (GLUT-2) and the glucose phosphorylating enzyme, glucokinase, are key regulators of the rate of glucose metabolism in liver and islets, the two 'glucose-sensing' tissues in mammals. Increases in circulating glucose stimulate insulin secretion from the ,%cells of the islets of Langerhans and convert the liver from an organ of net glucose output to one of glucose storage, processes mediated by increased glucose metabolism in both tissues.
The liver/islet high-K, facilitated glucose transporter (GLUT-2) and the glucose phosphorylating enzyme, glucokinase, are key regulators of the rate of glucose metabolism in liver and islets, the two 'glucose-sensing' tissues in mammals. Increases in circulating glucose stimulate insulin secretion from the ,%cells of the islets of Langerhans and convert the liver from an organ of net glucose output to one of glucose storage, processes mediated by increased glucose metabolism in both tissues.
Increases in islet glucose metabolism result in elevated levels of a number of intracellular compounds that are recognized as second messengers for insulin secretion, including intracellular Ca", inositol phosphates, arachidonic acid, diacylglycerol and ATP/ADP ratios (reviewed in [ 1-51). The @-cell glucose transporter, which has a K , for glucose of 17 mM and which has the same primary sequence as and similar kinetics to liver GLUT-2 161, probably plays a permissive role, by allowing rapid equilibration of intracellular and extracellular glucose. The rate of glucose metabolism is then largely controlled by glucokinase [ 2, 7-91. Perhaps the most compelling single piece of evidence supporting a regulatory role for the enzyme is that the curves for glucose dependence o f glucose usage (metabolism) and glucokinase activity in islets are virtually superimposable (see [2] ). The curve for glucokinase activity as a function of glucose concentration in both liver and islets is sigmoidal, and is particularly steep over the physiological range of glucose concentrations (4-10 mM). This means that even modest increments in circulating glucose can quickly be translated into substantial increases in glucose metabolism, through rapid transporter-mediated equilibration across the plasma membrane and phosphorylation by glucokinase.
It has been known for some time that islets isolated from fasted animals exhibit both an attenuated insulin secretory response to glucose and a reduction in glucokinase activity that is thought to be sufficient to account for the dampened response [lo, 111. Refeeding of fasted animals results in a return of glucokinase activity and glucose-stimulated insulin secretion to normal within a period of hours. Alterations in hepatic glucokinase activity as a consequence of dietary status are also well studied, and are similar in direction and magnitude to the changes observed in islets 1121. With the preparation of anti-glucokinase antibodies [ 131 and the cloning of the cDNA for hepatic glucokinase [14, 151, it has become possible to analyse the effects of dietary manipulation on the level of expression of glucokinase mRNA and protein in liver and islets and to correlate these changes with the known alterations in enzyme activity. In a recent collaborative study between our laboratory and that of Dr. Patrick lynedjian, important differences in the regulation and structure of the glucokinase gene products in liver and islets were observed 1161. A glucokinase cDNA probe prepared from hepatic mRNA [ 141 hybridized with equal intensity to a Abbrcviation used: GLUT-2, high-K, facilitated glucose *lo whom correspondence should be addressed. 2.8 kb glucokinase transcript in islet mRNA isolated from animals in the fasted, fed ad libitum or fasted/refed states. Western blot analysis revealed that these nutritional manipulations also had no effect on the level of glucokinase protein in islets. Liver mRNA isolated from rats fed ad libitum contained a single glucokinase transcript of 2.4 kb, clearly smaller than that detected in islets. Fasting of animals for 48 or 72 h resulted in a drop in liver glucokinase mRNA to undetectable levels. Refeeding of fasted animals, either by glucose gavage or ad libitum, caused a marked induction of glucokinase mRNA in liver within 4-6 h, to a level greater than seen in normally fed animals. In liver, fasting followed by glucose gavage resulted in a 3-fold increase in glucokinase protein compared with the fasted state. The relative increase in glucokinase protein amount in response to refeeding was clearly less than the increase in glucokinase mRNA induced by this manipulation [ 161.
It is known that liver glucokinase activity is dramatically reduced in insulin-deficient states, such as diabetes (reviewed in I 1211, or in the case of removal of an insulinoma tumour from NEDH rats [ 171, and that activity returns to normal upon administration of insulin. Recent studies have shown that the effect of insulin is largely mediated by a rapid and dramatic activation of glucokinase gene transcription in liver (occurring within 1 h) and consequent accumulation of glucokinase mRNA, while increases in enzyme activity and protein amount lag behind [ 181. Exposure of hepatocytes to glucagon, even in the presence of stimulatory concentrations of insulin, strongly inhibits glucokinase gene expression [ 1 Y], a finding that may help to explain the transient induction of mKNA that occurs in response to an insulin bolus in vivo [ 181. Studies on the direct effects of glucagon or insulin on expression of glucokinase in islets are currently not available.
Several conclusions can be drawn from these data.
( 1 ) Glucokinase expression is under differential control in liver and islets. Specifically, liver glucokinase mRNA levels are dramatically altered in response to fasting and refeeding, as are protein levels to a lesser extent, whereas neither glucokinase mRNA nor protein levels are changed in response to these manipulations in islets. (2) Thus, the reduction in glucokinase activity in islets of fasted animals, and the attendant decrease in glucose-stimulated insulin secretion, do not appear to be mediated by changes in glucokinase mRNA or protein amount in islet cells. This suggests that glucokinase is regulated in islets at the level of enzyme activity, possibly in response to alterations in the levels of allosteric ligands. Classically, glucokinase is not thought of as an allosteric enzyme, in contrast to the hexokinases, which are strongly inhibited by glucose &phosphate [20] . Recently, however, some precedent has begun to emerge for allosteric regulation of glucokinase activity. Glucokinase activity is inhibited by long-chain fatty acyl-Co A [ 2 11. Furthermore, stimulation of glucose phosphorylation by fructose in hepatocytes may be mediated by fructose 1 -phosphate antagonism of a heat-labile, trypsin-sensitive inhibitor of glucokinase [ 221. Also, phosphorylation of glucokinase by protein kinase A on serine residues has been reported to lead to its inactivation 1231. Although much less is known about regulation of islet glucokinase, its activity has been shown to be partially inhibited by alloxan 1241. It remains to be determined whether liver and islet glucokinases, which are similar but not identical proteins (see below), behave identically in the presence of putative allosteric ligands. (3) There is a single glucokinase gene in the rat genome [ 16, 25, 261 that is alternately transcribed and processed in liver and islets, to yield distinct mRNA species. Studies employing the techniques of molecular biology have led to an understanding of the structural basis for the differently sized messages (see below). (4) Regulation of liver glucokinase expression in response to dietary and/or hormonal changes is complex, and appears to involve changes in transcription, mRNA stability, and translation, and is further mediated by the long half-life of the glucokinase protein (30 h).
Islet glucokinase has been cloned from a normal rat cDNA library in our laboratory and from an insulinoma library and by amplification of total pancreas mRNA with the polymerase chain reaction by Magnuson & Shelton [26] . Comparison of the sequence with that for liver glucokinase [15] reveals that the two cDNAs are identical over a major portion, stretching from the codon for amino acid 15 (nucleotide 16 I , using the numbering system of Andreone et d. [ 151 for liver glucokinase) to the polyadenylation site at nucleotide 2329. The sequence encoding the first 15 amino acids, however, is clearly different, as shown in Fig. 1 . A striking distinction is that within the first 15 amino acids, islet glucokinase contains nine residues with formal charge, whereas liver glucokinase has only two. The islet clone encodes an active glucokinase protein, as demonstrated by its expression in bacteria (26al. It is possible that the charged N-terminus of islet glucokinase imparts a capacity for electrostatic interactions with other components of islet cells. In fact, subcellar fractionation of islet cells results in the equal distribution of a high-K, glucose phosphorylating activity to cytosolic and particulate fractions [ 271. Teleologically speaking, an ideal partner for electrostatic interaction with glucokinase would be the islet GLUT-2, since if such a complex forms, it would represent a highly efficient 'glucosesensing apparatus'. We have recently prepared an antibody against the islet-specific N-terminal glucokinase peptide [ 26a] that specifically recognizes a protein of approx. 52000 daltons in islet cell extracts, and that may allow immunocytochemical analysis of the intracellular distribution of glucokinase in the near future.
The above information, coupled with recent studies describing the structure of the rat glucokinase gene [25, 261, has led to a fairly complete understanding of the origin of distinct glucokinase mRNA and protein species in liver and islets. Each mature mRNA is comprised of 10 exons from the single glucokinase gene. The liver and islet transcripts both contain exons 2-10, but exon 1 is different in the tissuespecific mRNAs. The liver-specific exon 1 is located more proximal to the other exons, and is at least 12 kb downstream of the islet-specific exon 1 [26] . The islet-specific exon 1 is larger than its liver counterpart, accounting for the differently sized mRNAs [ 16,261. Although the exact factors and cis-acting sequences controlling differential regulation of the glucokinase gene in liver and islets remain to be identified, the structure of the gene does appear to provide a physical separation of the relevant regulatory regions.
Differential regulation of expression of GLUT-2 in liver and islets has also recently bcen observed by our group [ 281. Continuous insulin infusion for 5 or 12 days, with consequent hypoglycaemia (55 mg/l00 ml compared with 120 mg/100 ml in controls), results in a reduction of islet GLUT-2 mRNA levels, measured both by hybridization in sitir and Northern blot analysis, to undetectable levels. The reduction in GLUT-2 mRNA is accompanied by loss of a 17 mM K , component of glucose transport activity present in normal islets from insulin-infused rats and the abolition of glucose-stimulated insulin secretion [28] . In contrast, such infusions have no consistent effects on GLUT-2 levels in liver, as shown in Fig. 2 . Unlike the glucokinase system these tissue-specific alterations in GLUT-2 expression appear to be accomplished without alteration in the structurc of the mRNA in the two tissues. since they are the same size. and GLUT-2 clones from liver and islet cDNA libraries have the same sequence in both rats 161 and humans 1291. This suggests that there may be physiological circumstances in which glucokinase and GLUT-2 expression are differentially controlled, with consequent specific modulation of glucose metabolism in liver or islet cells. An example of differential alteration in GLUT-2 and glucokinase expression is given in 2 . Effect of long-term insirlin infiitsion on glircokinase and GLUT-2 expression in liver Unrestrained rats were infused with insulin or saline (controls) for 5 to 12 days. Northern blot analysis was performed with antisense RNA probes for glucokinase or liver/islet GLUT-2. An 18s rRNA oligonucleotide probe was also used to control for sample loading. The methods employed are described in detail in [28] . Glucokinase cDNA clones were isolated from an islet-specific library, prepared in our laboratory as described in [6] . Sequence analysis of the islet clones and comparison with the published sequence for liver glucokinase [ 1 51 revealed exact identity within the protein coding region, except over the N-terminal 15 amino acids. An alignment of the N-terminal residues and the encoding DNA for liver and islet glucokinases is shown. Residues bearing formal charge are indicated. Abbreviation: GK, glucokinase.
I990 Fig. 2 . Hepatic glucokinase mRNA levels are increased by 3-fold in rats infused with insulin for 5 days relative to salineinfused controls; a more prolonged insulin infusion of 12 days had no effect. In contrast. insulin infusion for either 5 or I2 days resulted in n o consistent change in GLUT-2 mRNA levels in liver. Despite the interesting and sometimes dramatic alterations in glucokinase mRNA and protein levels described above, the changes in activity of the enzyme in liver or islet tissues in response t o dietary manipulation are relatively modest. Decreases in islet glucokinase activity in response to 24-72 h of fasting are estimated at between 30 and 65%) [ 10, 1 1 1. The reduction in liver glucokinase activit in response to 24 h of fasting is similarly modest [ 12, 3 0 [ Nevertheless, these changes may be sufficient to alter glucose metabolism, and as a consequence, the 'glucose-sensing' function of these tissues. Thus, the islets exhibit markedly attenuated insulin secretion in response t o glucose when isolated from fasted rats. Reduced hepatic glucokinase activity in the fasted state may also prevent efficient deposition of glucose as glycogen in the liver by the 'direct' pathway, and thus act as a signal for the operation o f the 'indirect' pathway, wherein glycogen is synthesized largely from gluconeogenic precursors [ 301.
Reduced insulin secretion in fasting may also delay the induction of glucokinase in liver and allow glucagon t o stimulate liver gluconeogenesis in a relatively unopposed fashion for a significant period after termination of a fast. Preliminary studies suggest that GLUT-2 mRNA levels are not significantly altered in response to fasting and refeeding in either liver or islets (S. D. Hughes & C. B. Newgard, unpublished work). Normally, glucose transport capacity is far in excess of the rate of glucose metabolism in either liver or islets, so that modest changes in transport activity would likely have little effect on overall glucose disposal in these tissues. Loss of GLUT-2 function may become critical, however. in pathophysiological conditions, such as in noninsulin-dependent diabetes mellitus, where insulin resistance may lead to significant hyperinsulinaemia for prolonged periods and comprise GLUT-2 expression in islets. In short, continuing molecular and biochemical studies on the two components of the 'glucose-sensing apparatus' are warranted and will continue to be highly relevant to our understanding of the control of mammalian glucose homoeostasis.
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